TIDES Europe - Oligonucleotide & Peptide Therapeutics
Conference Details
Date: 03 November 2026
Time: 08:30
Duration: 3 days
Location: Amsterdam, Netherlands
Cost: £ 2999 - £ 5099
Organiser: Informa Connect
Conference Description
Join the leading oligonucleotides conference in Europe to access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies - from discovery to market.
Cross-Pollinate Expertise Across Oligonucleotides, Peptides, mRNA, Genome Editing and Drug Delivery
Cross-Fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas:
The TIDES Europe conference agenda features scientific tracks covering in-depth discovery, development and manufacturing strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.
Oligonucleotide Chemistry, Manufacturing & Controls
Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
Oligonucleotide Discovery, Preclinical and Clinical
Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Chemistry, Manufacturing & Controls
Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
Peptide Discovery, Preclinical and Clinical
Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
mRNA Therapeutics and Genome Editing
Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies
Macromolecular Drug Delivery
Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing
© EuroJobsites 2026